Obviously, there was no PFS or OS difference owing to PAPPA2 mutation in lung adenocarcinoma (LUAD), lung squamous carcinoma (LUSC), NSCLC or SKCM. This evidence concerns the gene PAPPA2 and lung adenocarcinoma.